SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1α in pulmonary epithelial and endothelial cells

Authors:

Abstract
Inflammasome assembly is a potent mechanism responsible for the host protection against pathogens, including viruses. When compromised, it can allow viral replication, while when disrupted, it can perpetuate pathological responses by IL-1 signaling and pyroptotic cell death. SARS-CoV-2 infection was shown to activate inflammasome in the lungs of COVID-19 patients, however, potential mechanisms responsible for this response are not fully elucidated. In this study, we investigated the effects of ORF3a, E and M SARS-CoV-2 viroporins in the inflammasome activation in major populations of alveolar sentinel cells: macrophages, epithelial and endothelial cells. We demonstrated that each viroporin is capable of activation of the inflammasome in macrophages to trigger pyroptosis-like cell death and IL-1α release from epithelial and endothelial cells. Small molecule NLRP3 inflammasome inhibitors reduced IL-1 release but weakly affected the pyroptosis. Importantly, we discovered that while SARS-CoV-2 could not infect the pulmonary microvascular endothelial cells it induced IL-1α and IL-33 release. Together, these findings highlight the essential role of macrophages as the major inflammasome-activating cell population in the lungs and point to endothelial cell expressed IL-1α as a potential novel component driving the pulmonary immunothromobosis in COVID-19.
Funding Information
  • Narodowe Centrum Nauki (UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19), UMO-2020/01/0/NZ6/00218 (COVID-19))
  • Bundesministerium für Forschung, Technologie und Raumfahrt (13N15745, 13N15745, 13N15745)

This publication has 47 references indexed in Scilit: